ENDEAVOR: carfilzomib new standard in multiple myeloma?

How can functional drug screening guide personalised cancer therapy?

How do genes influence the development of chronic idiopathic thrombocytopenic purpura?

Combining treatment options for higher risk myelodysplastic syndromes and chronic myelomonocytic leukaemia

ASH 2015: Highlights in mantle cell lymphoma

Incidence of and predictors for early death in paediatric patients with acute promyelocytic leukaemia

Blinatumomab has promising effect on hard-to-treat, rare acute lymphoblastic leukaemia subtype

Rituximab plus chemotherapy improves outcomes in acute lymphoblastic leukaemia

First all-oral treatment for relapsed and treatment-resistant multiple myeloma

Experimental oral therapy for high-risk CLL shows promise

Ibrutinib to treat elderly patients with chronic lymphocytic leukaemia

Idelalisib combination therapy in relapsed or treatment-resistant CLL better than standard regimen